Related references
Note: Only part of the references are listed.Post-treatment CT LI-RADS categories: predictors of overall survival in hepatocellular carcinoma post bland transarterial embolization
William E. L. Ormiston et al.
ABDOMINAL RADIOLOGY (2021)
Predicting survival after liver transplantation in patients with hepatocellular carcinoma using the LiTES-HCC score
David Goldberg et al.
JOURNAL OF HEPATOLOGY (2021)
II. Incorporating Tumour Biology to Predict HCC Recurrence in Patients Undergoing LDLT Using Expanded Selection Criteria
Manav Wadhawan et al.
JOURNAL OF CLINICAL AND EXPERIMENTAL HEPATOLOGY (2021)
The Key Role of Staging Definitions for Assessment of Downstaging for Hepatocellular Carcinoma
Francis Y. Yao et al.
SEMINARS IN LIVER DISEASE (2021)
Locoregional Treatments for Bridging and Downstaging HCC to Liver Transplantation
Laura Crocetti et al.
CANCERS (2021)
Dynamic α-Fetoprotein Response and Outcomes After Liver Transplant for Hepatocellular Carcinoma
Karim J. Halazun et al.
JAMA SURGERY (2021)
Downstaging Outcomes for Hepatocellular Carcinoma: Results From the Multicenter Evaluation of Reduction in Tumor Size before Liver Transplantation (MERITS-LT) Consortium
Neil Mehta et al.
GASTROENTEROLOGY (2021)
Incorporating Tumor Biology to Predict Hepatocellular Carcinoma Recurrence in Patients Undergoing Living Donor Liver Transplantation Using Expanded Selection Criteria
Prashant Bhangui et al.
LIVER TRANSPLANTATION (2021)
National Experience on Down-Staging of Hepatocellular Carcinoma Before Liver Transplant: Influence of Tumor Burden, Alpha-Fetoprotein, and Wait Time
Neil Mehta et al.
HEPATOLOGY (2020)
OPTN/SRTR 2018 Annual Data Report: Liver
A. Kwong et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2020)
Epidemiology and surveillance for hepatocellular carcinoma: New trends
Amit G. Singal et al.
JOURNAL OF HEPATOLOGY (2020)
Effect of Mandatory 6-Month Waiting Period on Waitlist and Transplant Outcomes in Patients With Hepatocellular Carcinoma
Shunji Nagai et al.
HEPATOLOGY (2020)
Liver transplantation in hepatocellular carcinoma after tumour downstaging (XXL): a randomised, controlled, phase 2b/3 trial
Vincenzo Mazzaferro et al.
LANCET ONCOLOGY (2020)
Are There Upper Limits in Tumor Burden for Down-Staging of Hepatocellular Carcinoma to Liver Transplant? Analysis of the All-Comers Protocol
Jasmine Sinha et al.
HEPATOLOGY (2019)
Liver transplantation and waitlist mortality for HCC and non-HCC candidates following the 2015 HCC exception policy change
Tanveen Ishaque et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2019)
Alpha-Fetoprotein Decrease from > 1,000 to < 500 ng/mL in Patients with Hepatocellular Carcinoma Leads to Improved Posttransplant Outcomes
Neil Mehta et al.
HEPATOLOGY (2019)
Predictors of low risk for dropout from the liver transplant waiting list for hepatocellular carcinoma in long wait time regions: Implications for organ allocation
Neil Mehta et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2019)
Excellent Outcomes of Liver Transplantation Following Down-Staging of Hepatocellular Carcinoma to Within Milan Criteria: A Multicenter Study
Neil Mehta et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2018)
Metroticket 2.0 Model for Analysis of Competing Risks of Death After Liver Transplantation for Hepatocellular Carcinoma
Vincenzo Mazzaferro et al.
GASTROENTEROLOGY (2018)
Liver Imaging Reporting and Data System (LI-RADS) Version 2018: Imaging of Hepatocellular Carcinoma in At-Risk Patients
Victoria Chernyak et al.
RADIOLOGY (2018)
Is it Time to Abandon the Milan Criteria? Results of a Bicoastal US Collaboration to Redefine Hepatocellular Carcinoma Liver Transplantation Selection Policies
Karim J. Halazun et al.
ANNALS OF SURGERY (2018)
Intention-to-Treat Survival Benefit of Liver Transplantation in Patients With Hepatocellular Cancer
Quirino Lai et al.
HEPATOLOGY (2017)
Wait Time of Less Than 6 and Greater Than 18 Months Predicts Hepatocellular Carcinoma Recurrence After Liver Transplantation: Proposing a Wait Time Sweet Spot
Neil Mehta et al.
TRANSPLANTATION (2017)
Validation of a Risk Estimation of Tumor Recurrence After Transplant (RETREAT) Score for Hepatocellular Carcinoma Recurrence After Liver Transplant
Neil Mehta et al.
JAMA ONCOLOGY (2017)
Development and validation of the HALT-HCC score to predict mortality in liver transplant recipients with hepatocellular carcinoma: a retrospective cohort analysis
Kazunari Sasaki et al.
LANCET GASTROENTEROLOGY & HEPATOLOGY (2017)
Recurrence After Liver Transplantation for Hepatocellular Carcinoma A New MORAL to the Story
Karim J. Halazun et al.
ANNALS OF SURGERY (2017)
Reassessing the Boundaries of Liver Transplantation for Hepatocellular Carcinoma: Where Do We Stand With Tumor Down-Staging?
Francis Y. Yao et al.
HEPATOLOGY (2016)
Serum Tumor Markers Provide Refined Prognostication in Selecting Liver Transplantation Candidate for Hepatocellular Carcinoma Patients Beyond the Milan Criteria
Jeong-Hoon Lee et al.
ANNALS OF SURGERY (2016)
The Extended Toronto Criteria for Liver Transplantation in Patients With Hepatocellular Carcinoma: A Prospective Validation Study
Gonzalo Sapisochin et al.
HEPATOLOGY (2016)
Complete Pathologic Response to Pretransplant Locoregional Therapy for Hepatocellular Carcinoma Defines Cancer Cure After Liver Transplantation Analysis of 501 Consecutively Treated Patients
Vatche G. Agopian et al.
ANNALS OF SURGERY (2015)
Comparison of Liver Transplant-Related Survival Benefit in Patients With Versus Without Hepatocellular Carcinoma in the United States
Kristin Berry et al.
GASTROENTEROLOGY (2015)
Downstaging of hepatocellular cancer before liver transplant: Long-term outcome compared to tumors within Milan criteria
Francis Y. Yao et al.
HEPATOLOGY (2015)
Total tumor volume and alpha-fetoprotein for selection of transplant candidates with hepatocellular carcinoma: A prospective validation
Christian Toso et al.
HEPATOLOGY (2015)
Combinations of Biomarkers and Milan Criteria for Predicting Hepatocellular Carcinoma Recurrence After Liver Transplantation
Roongruedee Chaiteerakij et al.
LIVER TRANSPLANTATION (2015)
Prognostic Relevance of Objective Response According to EASL Criteria and mRECIST Criteria in Hepatocellular Carcinoma Patients Treated with Loco-Regional Therapies: A Literature-Based Meta-Analysis
Bruno Vincenzi et al.
PLOS ONE (2015)
Standing the Test of Time: Outcomes of a Decade of Prioritizing Patients With Hepatocellular Carcinoma, Results of the UNOS Natural Geographic Experiment
Karim J. Halazun et al.
HEPATOLOGY (2014)
Alpha-Fetoprotein Level > 1000 ng/mL as an Exclusion Criterion for Liver Transplantation in Patients With Hepatocellular Carcinoma Meeting the Milan Criteria
Bilal Hameed et al.
LIVER TRANSPLANTATION (2014)
Serum alpha-fetoprotein level independently predicts posttransplant survival in patients with hepatocellular carcinoma
Kristin Berry et al.
LIVER TRANSPLANTATION (2013)
Identification of Liver Transplant Candidates With Hepatocellular Carcinoma and a Very Low Dropout Risk: Implications for the Current Organ Allocation Policy
Neil Mehta et al.
LIVER TRANSPLANTATION (2013)
Usefulness of the Kyoto criteria as expanded selection criteria for liver transplantation for hepatocellular carcinoma
Toshimi Kaido et al.
SURGERY (2013)
Liver Transplantation for Hepatocellular Carcinoma: A Model Including α-Fetoprotein Improves the Performance of Milan Criteria
Christophe Duvoux et al.
GASTROENTEROLOGY (2012)
Increasing disparity in waitlist mortality rates with increased model for end-stage liver disease scores for candidates with hepatocellular carcinoma versus candidates without hepatocellular carcinoma
David Goldberg et al.
LIVER TRANSPLANTATION (2012)
Hepatocellular Carcinoma: Ablate and Wait Versus Rapid Transplantation
John P. Roberts et al.
LIVER TRANSPLANTATION (2010)
Report of a National conference on Liver Allocation in Patients with Hepatocellular Carcinoma in the United States
Elizabeth A. Pomfret et al.
LIVER TRANSPLANTATION (2010)
Modified RECIST (mRECIST) Assessment for Hepatocellular Carcinoma
Riccardo Lencioni et al.
SEMINARS IN LIVER DISEASE (2010)
Predicting survival after liver transplantation in patients with hepatocellular carcinoma beyond the Milan criteria: a retrospective, exploratory analysis
Vincenzo Mazzaferro et al.
LANCET ONCOLOGY (2009)
Liver transplantation for hepatocellular carcinoma: Validation of the UCSF-Expanded criteria based on preoperative imaging
F. Y. Yao et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2007)
Liver transplantation criteria for hepatocellular carcinoma should be expanded - A 22-year experience with 467 patients at UCLA
John P. Duffy et al.
ANNALS OF SURGERY (2007)
Response to transarterial chemoembolization as a biological selection criterion for liver transplantation in hepatocellular carcinoma
Gerd Otto et al.
LIVER TRANSPLANTATION (2006)
The survival benefit of liver transplantation
RM Merion et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2005)
Liver transplantation for hepatocellular carcinoma: Expansion of the tumor size limits does not adversely impact survival
FY Yao et al.
HEPATOLOGY (2001)
Share Paper
